Navigation Links
Co-sponsors highlight important research to be presented at the 2013 Breast Cancer Symposium

SAN FRANSISCO, CA Five additional studies of note are among those that will be presented at the 2013 Breast Cancer Symposium, taking place September 7-9, 2013 at the San Francisco Marriott Marquis in San Francisco, California. Two studies examine cognitive function in women who undergo treatment for early-stage breast cancer; a third evaluates impact of tumor genotyping on clinical trial enrollment; and the final two evaluate the outcomes of different treatment approaches.

Saturday, September 7 Presentations

Abstract #48:
Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcome.

General Poster Session A
Saturday, September 7, 2013, 11:30 AM 1:00 PM PST
Saturday, September 7, 2013, 4:30 PM 6:00 PM PST
Golden Gate Hall

Napa Parinyanitikul, MD
The University of Texas MD Anderson Cancer Center
Houston, TX

Abstract # 55:
Ten-year outcomes of accelerated partial breast irradiation compared with whole breast irradiation: A matched-pair analysis.

Poster Discussion A
Saturday, September 7, 2013, 4:00 PM 4:20 PM PST
Yerba Buena Ballroom, Salon 8

Jessica Wobb, MD
Oakland University William Beaumont School of
Medicine, Beaumont Cancer Institute
Royal Oak, MI

Sunday, September 8 Presentations

Abstract # 105:
Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.

Poster Discussion B
Sunday, September 8, 2013, 3:00 PM 3:20 PM PST
Yerba Buena Ballroom, Salon 8

Lara Heflin, PhD
New Mexico Highlands University
Las Vegas, NM

Abstract # 104:
Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.

Poster Discussion B
Sunday, September 8, 2013, 3:00 PM 3:20 PM PST
Yerba Buena Ballroom, Salon 8

Hope S. Rugo, MD
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Abstract # 145:
Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.

Poster Discussion B
Sunday, September 8, 2013, 4:00 PM 4:20 PM PST
Yerba Buena Ballroom, Salon 8

Aditya Bardia, MD
Massachusetts General Hospital,
Harvard Medical School
Boston, MA


Contact: Kate Blackburn
American Society of Clinical Oncology

Related medicine news :

1. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
2. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
3. Scientific session and new research highlights
4. Triple negative breast cancer symposium highlights current advances
5. Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment
6. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
7. New influenza virus from seals highlights the risks of pandemic flu from animals
8. JAAOS study highlights success of nerve transfer surgery
9. Researchers highlight treatment, research needs for homeless families
10. Deadly outbreak of West Nile virus highlights urgent need for more research, funding
11. AAO-HNSF 2012 new oral research daily highlights
Post Your Comments:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. ... ...
Breaking Medicine Technology: